AAAAAA
Results:
1-19
|
Results: 19
Authors:
Akkerhuis, KM
van den Brand, MJBM
van der Zwaan, C
Peels, HOJ
Suryapranata, H
van der Wieken, LR
Stibbe, J
Hoffmann, J
Baardman, T
Deckers, JW
Simoons, ML
Citation: Km. Akkerhuis et al., Pharmacodynamics and safety of lefradafiban, an oral platelet glycoproteinIIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty, HEART, 85(4), 2001, pp. 444-450
Authors:
Deckers, JW
Citation: Jw. Deckers, Smoking and survival in acute coronary syndrome: the fog is clearing, EUR HEART J, 22(9), 2001, pp. 724-726
Authors:
Deckers, JW
Van Domburg, R
Cats, VM
Peters, RJG
Citation: Jw. Deckers et al., Public risk factor screening on the occasion of the ESC meeting in Amsterdam - results from 'For Your Heart's Sake', EUR HEART J, 22(21), 2001, pp. 2025-2026
Authors:
Mosterd, A
Cost, B
Hoes, AW
de Bruijne, MC
Deckers, JW
Hofman, A
Grobbee, DE
Citation: A. Mosterd et al., The prognosis of heart failure in the general population - The Rotterdam Study, EUR HEART J, 22(15), 2001, pp. 1318-1327
Authors:
Kotseva, K
Wood, D
De Backer, G
De Bacquer, D
Pyorala, K
Keil, U
Sans, S
Ambrosio, GB
Amouyel, P
Cokkinos, D
Deckers, JW
Erhardt, L
Graham, I
Gutzwiller, F
Keber, I
Keil, U
Lehto, S
Ostor, E
Pajak, A
Sans, S
Simon, J
Turk, J
Wood, D
Wood, DA
Schofield, B
Bowker, T
Ingham, J
McLennan, N
Kotseva, K
Gollapalli, M
Valay, R
De Backer, G
De Bacquer, D
James, D
Mackness, M
Simon, J
Linhartova, K
Hafman, P
Mayer, O
Rosolova, H
Bocek, P
Hrncarek, M
Lupinek, P
Marek, T
Plaskova, M
Skodova, Z
Cifkova, R
Lehto, S
Lehto, R
Kemppainen, A
Koukkunen, H
Luukkonen, J
Puhakka, M
Karkkainen, K
Savolainen, K
Amouyel, P
Montaye, M
Lemaire, B
Danet, S
Domanievicz, R
Lenoir, M
Beauchant, S
Dusart, A
Bonte, F
Fievet, N
Poissonnier, L
Ledoux, P
Marecaux, N
Steclebout, C
Keil, U
Liese, A
Broxtermann, U
Heimbach, M
Heidrich, J
Kalic, M
Breithardt, G
Enbergs, A
Kerber, S
Scheld, H
Roeder, N
Kleine-Katthofer, P
Assmann, G
Ostor, E
Borbas, S
Podmaniczky, M
Ruzsanyi, T
Janosi, A
Belatiny-Kenez, A
Bradak, A
Adam, Z
Barczy, G
Birtalan, K
Gallai, I
Ambrosio, GB
Leprotti, C
Zardini, P
Rossi, L
Gallo, A
Tavella, D
Stritoni, P
Pedrocco, A
Perissinotto, F
Vanuzzo, D
Pilotto, L
Deckers, JW
Post, F
Jansen, C
Veerhoek, M
Boer, A
Stockx, E
van de Berg, R
Remme, WJ
van Vliet, R
Vos, J
van der Knaap, M
Turk, J
Keber, I
Marn, K
Salapura, V
Skof, E
Span, E
Sans, S
Paluzie, G
Perez, I
Puig, T
Varas, C
Balana, L
Lopez, FN
Sanz, G
Ferrer, C
de Luna, AB
Caralps, JM
Dominguez, M
Monras, P
Rey, M
Citation: K. Kotseva et al., Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries, LANCET, 357(9261), 2001, pp. 995-1001
Authors:
Akkerhuis, KM
Deckers, JW
Lincoff, AM
Tcheng, JE
Boersma, E
Anderson, K
Balog, C
Califf, RM
Topol, EJ
Simoons, ML
Citation: Km. Akkerhuis et al., Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention, J AM MED A, 286(1), 2001, pp. 78-82
Authors:
Peterson, JG
Topol, EJ
Roe, MT
Sapp, SK
Lincoff, AM
Deckers, JW
Blackstone, EH
Harrington, RA
Califf, RM
Lauer, MS
Citation: Jg. Peterson et al., Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes, AM J CARD, 87(5), 2001, pp. 532-536
Authors:
Akkerhuis, KM
Deckers, JW
Boersma, E
Harrington, RA
Stepinska, J
Mahaffey, KW
Wilcox, RG
Lincoff, AM
Keltai, M
Topol, EJ
Califf, RM
Simoons, ML
Citation: Km. Akkerhuis et al., Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT, EUR HEART J, 21(5), 2000, pp. 371-381
Authors:
Akkerhuis, KM
Neuhaus, KL
Wilcox, RG
Vahanian, A
Boland, JL
Hoffmann, J
Baardman, T
Nehmiz, G
Roth, U
Klootwijk, APJ
Deckers, JW
Simoons, ML
Citation: Km. Akkerhuis et al., Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation - A phase II study, EUR HEART J, 21(24), 2000, pp. 2042-2055
Authors:
van der Vlugt, MJ
Boersma, H
Leenders, CM
Pop, GAM
Veerhoek, MJ
Simoons, ML
Deckers, JW
Citation: Mj. Van Der Vlugt et al., Prospective study of early discharge after acute myocardial infarction (SHORT), EUR HEART J, 21(12), 2000, pp. 992-999
Authors:
Alexander, JH
Sparapani, RA
Mahaffey, KW
Deckers, JW
Newby, LK
Ohman, EM
Corbalan, R
Chierchia, SL
Boland, JB
Simoons, ML
Califf, RM
Topol, EJ
Harrington, RA
Citation: Jh. Alexander et al., Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation, J AM MED A, 283(3), 2000, pp. 347-353
Authors:
Boersma, E
Pieper, KS
Steyerberg, EW
Wilcox, RG
Chang, WC
Lee, KL
Akkerhuis, KM
Harrington, RA
Deckers, JW
Armstrong, PW
Lincoff, AM
Califf, RM
Topol, EJ
Simoons, ML
Citation: E. Boersma et al., Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients, CIRCULATION, 101(22), 2000, pp. 2557-2567
Authors:
Karsch, KR
Deckers, JW
Citation: Kr. Karsch et Jw. Deckers, Confronting the challenge of acute ischaemic coronary syndromes - Proceedings of two satellite symposia to the XXth Congress of the European Society of Cardiology, Vienna, Austria, August 1998 - Foreword, EUR H J SUP, 1(N), 1999, pp. N1-N1
Authors:
Mosterd, A
Hoes, AW
de Bruyne, MC
Deckers, JW
Linker, DT
Hofman, A
Grobbee, DE
Citation: A. Mosterd et al., Prevalence of heart failure and left ventricular dysfunction in the general population - The Rotterdam Study, EUR HEART J, 20(6), 1999, pp. 447-455
Authors:
van Berkel, TFM
Boersma, H
De Baquer, D
Deckers, JW
Wood, D
Citation: Tfm. Van Berkel et al., Registration and management of smoking behaviour in patients with coronaryheart disease - The EUROASPIRE survey, EUR HEART J, 20(22), 1999, pp. 1630-1637
Authors:
Klootwijk, P
Lenderink, T
Meij, S
Boersma, H
Melkert, R
Umans, VAW
Stibbe, J
Muller, EJ
Poortermans, KJ
Deckers, JW
Simoons, ML
Citation: P. Klootwijk et al., Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina, EUR HEART J, 20(15), 1999, pp. 1101-1111
Authors:
Maas, ACP
van Domburg, RT
Deckers, JW
Vermeer, F
Remme, WJ
Kamp, O
Cats, VM
Simoons, ML
Citation: Acp. Maas et al., Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction, EUR HEART J, 20(11), 1999, pp. 819-826
Authors:
Simoons, ML
Boersma, E
van der Zwaan, C
Deckers, JW
Citation: Ml. Simoons et al., The challenge of acute coronary syndromes, LANCET, 353, 1999, pp. SII1-SII4
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes
Authors:
Alexander, JH
Harrington, RA
Tuttle, RH
Berdan, LG
Lincoff, AM
Deckers, JW
Simoons, ML
Guerci, A
Hochman, JS
Wilcox, RG
Kitt, MM
Eisenberg, PR
Califf, RM
Topol, EJ
Karsh, K
Ruzyllo, W
Stepinska, J
Widimsky, P
Boland, JB
Armstrong, PW
Citation: Jh. Alexander et al., Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes, AM J CARD, 83(8), 1999, pp. 1147-1151
Risultati:
1-19
|